Gregory Cheng

synertechcare australia pty ltd.

H指数:37

被引数:9,880

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fermented rice bran extract delays skin aging by increasing the synthesis of collagen and elastin

发酵米糠提取物通过增加胶原蛋白和弹性蛋白的合成来延缓皮肤衰老。

Frontiers in Pharmacology

IF4.8

2025-11-180

OAAI

APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024

HEPATOLOGY INTERNATIONAL

IF6.1

2024-11-212

Lau, George; Obi, Shuntaro; Zhou, Jian; Tateishi, Ryosuke; Qin, Shukui; Zhao, Haitao; Otsuka, Motoyuki; Ogasawara, Sadahisa; George, Jacob; Chow, Pierce K. H.; Cai, Jianqiang; Shiina, Shuichiro; Kato, Naoya; Yokosuka, Osamu; Oura, Kyoko; Yau, Thomas; Chan, Stephen L.; Kuang, Ming; Ueno, Yoshiyuki; Chen, Minshan; Cheng, Ann-Lii; Cheng, Gregory; Chuang, Wan-Long; Baatarkhuu, Oidov; Bi, Feng; Dan, Yock Young; Gani, Rino A.; Tanaka, Atsushi; Jafri, Wasim; Jia, Ji-Dong; Kao, Jia-Horng; Hasegawa, Kiyoshi; Lau, Patrick; Lee, Jeong Min; Liang, Jun; Liu, Zhenwen; Lu, Yinying; Pan, Hongming; Payawal, Diana A.; Rahman, Salimur; Seong, Jinsil; Shen, Feng; Shiha, Gamal; Song, Tianqiang; Sun, Hui-Chuan; Masaki, Tsutomu; Sirachainan, Ekaphop; Wei, Lai; Yang, Jin Mo; Sallano, Jose D.; Zhang, Yanqiao; Tanwandee, Tawesak; Dokmeci, Akadir; Zheng, Shu-sen; Fan, Jia; Fan, Sheung-Tat; Sarin, Shiv Kumar; Omata, Masao

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)

HEPATOLOGY INTERNATIONAL

IF6.1

2022-01-253

OAAI

Lau, George; Yu, Ming-Lung; Wong, Grace; Thompson, Alexander; Ghazinian, Hasmik; Hou, Jin-Lin; Piratvisuth, Teerha; Jia, Ji-Dong; Mizokami, Masashi; Cheng, Gregory; Chen, Guo-Feng; Liu, Zhen-Wen; Baatarkhuu, Oidov; Cheng, Ann Lii; Ng, Woon Leung; Lau, Patrick; Mok, Tony; Chang, Jer-Ming; Hamid, Saeed; Dokmeci, A. Kadir; Gani, Rino A.; Payawal, Diana A.; Chow, Pierce; Park, Joong-Won; Strasser, Simone I.; Mohamed, Rosmawaiti; Win, Khin Maung; Tanwandee, Tawesak; Sarin, Shiv Kumar; Omata, Masao

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

与使用免疫抑制治疗相关的乙型肝炎再激活的APASL临床实践指南

HEPATOLOGY INTERNATIONAL

IF6.1

2021-08-24100

OAAI

Lau, George; Yu, Ming-Lung; Wong, Grace; Thompson, Alexander; Ghazinian, Hasmik; Hou, Jin-Lin; Piratvisuth, Teerha; Jia, Ji-Dong; Mizokami, Masashi; Cheng, Gregory; Chen, Guo-Feng; Liu, Zhen-Wen; Baatarkhuu, Oidov; Cheng, Ann Lii; Ng, Woon Leung; Lau, Patrick; Mok, Tony; Chang, Jer-Ming; Hamid, Saeed; Dokmeci, A. Kadir; Gani, Rino A.; Payawal, Diana A.; Chow, Pierce; Park, Joong-Won; Strasser, Simone, I; Mohamed, Rosmawaiti; Win, Khin Maung; Tawesak, Tanwandee; Sarin, Shiv Kumar; Omata, Masao

Reply to: NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues

JOURNAL OF HEPATOLOGY

IF33

2021-02-018

OAAI

Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2021-02-0118

OAAI

The Inherent Problems With the Generalizability of the CALL Score: Towards Reliable Clinical Prediction Models for Coronavirus Disease 2019 (COVID-19) Reply

CLINICAL INFECTIOUS DISEASES